Corvus Pharmaceuticals Stock Price History
| CRVS Stock | USD 5.01 0.28 5.92% |
Below is the normalized historical share price chart for Corvus Pharmaceuticals extending back to March 23, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corvus Pharmaceuticals stands at 5.01, as last reported on the 18th of January 2025, with the highest price reaching 5.12 and the lowest price hitting 4.66 during the day.
If you're considering investing in Corvus Stock, it is important to understand the factors that can impact its price. Corvus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0654, which signifies that the company had a -0.0654% return per unit of risk over the last 3 months. Corvus Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Corvus Pharmaceuticals' Mean Deviation of 4.04, risk adjusted performance of (0.02), and Standard Deviation of 6.4 to double-check the risk estimate we provide.
At this time, Corvus Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 68.5 M in 2025, whereas Other Stockholder Equity is likely to drop slightly above 230.8 M in 2025. . At this time, Corvus Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.06 in 2025, whereas Price To Operating Cash Flows Ratio is likely to drop (3.34) in 2025. Corvus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of March 2016 | 200 Day MA 4.3853 | 50 Day MA 7.2486 | Beta 1.044 |
Corvus |
Sharpe Ratio = -0.0654
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRVS |
Estimated Market Risk
| 6.46 actual daily | 57 57% of assets are less volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Corvus Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corvus Pharmaceuticals by adding Corvus Pharmaceuticals to a well-diversified portfolio.
Corvus Pharmaceuticals Stock Price History Chart
There are several ways to analyze Corvus Stock price data. The simplest method is using a basic Corvus candlestick price chart, which shows Corvus Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 9.56 |
| Lowest Price | December 23, 2024 | 4.55 |
Corvus Pharmaceuticals January 18, 2025 Stock Price Synopsis
Various analyses of Corvus Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Corvus Stock. It can be used to describe the percentage change in the price of Corvus Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Corvus Stock.| Corvus Pharmaceuticals Price Rate Of Daily Change | 1.06 | |
| Corvus Pharmaceuticals Price Daily Balance Of Power | 0.61 | |
| Corvus Pharmaceuticals Price Action Indicator | 0.26 |
Corvus Pharmaceuticals January 18, 2025 Stock Price Analysis
Corvus Stock Price History Data
The price series of Corvus Pharmaceuticals for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 5.01 with a coefficient of variation of 21.25. The prices are distributed with arithmetic mean of 7.36. The median price for the last 90 days is 8.03.| Open | High | Low | Close | Volume | ||
01/18/2025 | 4.71 | 5.12 | 4.66 | 5.01 | ||
| 01/17/2025 | 4.71 | 5.12 | 4.66 | 5.01 | 719,048 | |
| 01/16/2025 | 4.91 | 4.92 | 4.60 | 4.73 | 864,013 | |
| 01/15/2025 | 5.12 | 5.30 | 4.88 | 4.92 | 650,708 | |
| 01/14/2025 | 5.18 | 5.32 | 5.00 | 5.10 | 629,489 | |
| 01/13/2025 | 5.31 | 5.33 | 5.09 | 5.20 | 604,089 | |
| 01/10/2025 | 5.50 | 5.58 | 5.26 | 5.33 | 525,125 | |
| 01/08/2025 | 5.78 | 5.89 | 5.53 | 5.65 | 388,885 | |
| 01/07/2025 | 6.05 | 6.14 | 5.75 | 5.75 | 562,900 | |
| 01/06/2025 | 5.97 | 6.47 | 5.83 | 6.03 | 821,347 | |
| 01/03/2025 | 5.43 | 5.93 | 5.38 | 5.83 | 802,507 | |
| 01/02/2025 | 5.46 | 5.68 | 5.25 | 5.43 | 910,108 | |
| 12/31/2024 | 5.24 | 5.36 | 4.99 | 5.35 | 786,719 | |
| 12/30/2024 | 5.01 | 5.28 | 4.93 | 5.25 | 752,062 | |
| 12/27/2024 | 5.22 | 5.43 | 5.10 | 5.21 | 944,069 | |
| 12/26/2024 | 4.84 | 5.40 | 4.84 | 5.29 | 1,207,333 | |
| 12/24/2024 | 4.56 | 4.94 | 4.55 | 4.90 | 658,069 | |
| 12/23/2024 | 4.95 | 4.95 | 4.52 | 4.55 | 1,286,558 | |
| 12/20/2024 | 5.02 | 5.34 | 4.73 | 4.99 | 2,585,379 | |
| 12/19/2024 | 4.67 | 5.10 | 4.30 | 5.09 | 2,416,659 | |
| 12/18/2024 | 5.00 | 5.20 | 3.77 | 4.70 | 14,074,650 | |
| 12/17/2024 | 6.44 | 7.44 | 6.44 | 7.39 | 1,292,052 | |
| 12/16/2024 | 7.28 | 7.40 | 6.88 | 6.90 | 1,193,196 | |
| 12/13/2024 | 8.07 | 8.22 | 7.29 | 7.38 | 1,718,518 | |
| 12/12/2024 | 7.96 | 8.33 | 7.96 | 8.08 | 887,648 | |
| 12/11/2024 | 8.03 | 8.25 | 7.88 | 8.11 | 933,565 | |
| 12/10/2024 | 8.20 | 8.49 | 7.98 | 8.02 | 577,816 | |
| 12/09/2024 | 8.27 | 8.43 | 8.00 | 8.15 | 444,790 | |
| 12/06/2024 | 8.12 | 8.49 | 7.98 | 8.26 | 477,088 | |
| 12/05/2024 | 8.03 | 8.29 | 8.00 | 8.13 | 555,041 | |
| 12/04/2024 | 8.20 | 8.36 | 8.01 | 8.03 | 609,407 | |
| 12/03/2024 | 8.16 | 8.28 | 7.95 | 8.28 | 1,119,684 | |
| 12/02/2024 | 9.04 | 9.16 | 8.20 | 8.25 | 839,470 | |
| 11/29/2024 | 9.50 | 9.55 | 9.09 | 9.09 | 321,732 | |
| 11/27/2024 | 8.74 | 9.50 | 8.63 | 9.42 | 392,754 | |
| 11/26/2024 | 9.00 | 9.25 | 8.60 | 8.73 | 393,896 | |
| 11/25/2024 | 9.07 | 9.35 | 8.87 | 8.93 | 712,478 | |
| 11/22/2024 | 8.95 | 9.19 | 8.79 | 8.95 | 1,208,881 | |
| 11/21/2024 | 8.24 | 9.05 | 8.04 | 8.94 | 820,768 | |
| 11/20/2024 | 8.34 | 8.39 | 8.02 | 8.24 | 551,941 | |
| 11/19/2024 | 8.17 | 8.61 | 8.16 | 8.40 | 808,658 | |
| 11/18/2024 | 8.26 | 8.71 | 8.16 | 8.34 | 636,972 | |
| 11/15/2024 | 8.40 | 8.51 | 7.78 | 8.19 | 2,348,907 | |
| 11/14/2024 | 8.94 | 9.00 | 7.89 | 8.52 | 1,218,417 | |
| 11/13/2024 | 9.96 | 10.00 | 8.79 | 8.87 | 1,272,803 | |
| 11/12/2024 | 9.40 | 9.70 | 8.67 | 8.69 | 673,902 | |
| 11/11/2024 | 9.63 | 9.90 | 9.28 | 9.56 | 574,403 | |
| 11/08/2024 | 8.71 | 9.61 | 8.62 | 9.45 | 754,123 | |
| 11/07/2024 | 8.67 | 9.10 | 8.43 | 8.80 | 1,083,121 | |
| 11/06/2024 | 9.66 | 9.70 | 8.50 | 8.78 | 1,634,072 | |
| 11/05/2024 | 8.93 | 9.44 | 8.87 | 9.23 | 1,064,429 | |
| 11/04/2024 | 8.99 | 9.37 | 7.91 | 9.02 | 1,390,567 | |
| 11/01/2024 | 8.95 | 9.28 | 8.82 | 9.10 | 655,825 | |
| 10/31/2024 | 8.66 | 9.03 | 8.51 | 8.84 | 538,689 | |
| 10/30/2024 | 9.00 | 9.19 | 8.55 | 8.80 | 734,268 | |
| 10/29/2024 | 8.61 | 8.96 | 8.45 | 8.89 | 641,123 | |
| 10/28/2024 | 8.65 | 9.08 | 8.51 | 8.64 | 1,857,508 | |
| 10/25/2024 | 7.78 | 8.69 | 7.74 | 8.31 | 1,618,802 | |
| 10/24/2024 | 7.64 | 8.18 | 7.57 | 7.68 | 1,309,445 | |
| 10/23/2024 | 7.69 | 7.83 | 7.03 | 7.56 | 1,054,456 | |
| 10/22/2024 | 7.79 | 8.33 | 7.56 | 7.75 | 1,572,471 |
About Corvus Pharmaceuticals Stock history
Corvus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corvus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corvus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corvus Pharmaceuticals stock prices may prove useful in developing a viable investing in Corvus Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 55.2 M | 30.7 M | |
| Net Loss | -37.2 M | -39 M |
Corvus Pharmaceuticals Stock Technical Analysis
Corvus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Corvus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corvus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Corvus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corvus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.35) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Corvus Stock Analysis
When running Corvus Pharmaceuticals' price analysis, check to measure Corvus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corvus Pharmaceuticals is operating at the current time. Most of Corvus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corvus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corvus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corvus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.